Cooper Investors Pty »

Halozyme Therapeutics shares owned by Cooper Investors Pty

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Cooper Investors Pty from 13F filings

Historical chart of Cooper Investors Pty investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Cooper Investors Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Cooper Investors Pty

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.3M 55k 78.27

More positions owned by Cooper Investors Pty

Pershing Square USA
Shenandoah Telecommunications Company (SHEN)
Uber Technologies (UBER)
Stevanato Group S P A (STVN)
Liberty Media Corp Del Com Lbty One S C (FWONK)
Liberty Media Corp Del (FWONA)
iShares MSCI ACWI Index Fund (ACWI)
Royalty Pharma (RPRX)
Alphabet Inc Class A cs (GOOGL)
Ferrovial Se (FER)
Telephone And Data Systems (TDS)
Liberty Live Holdings Inc Com Ser A (LLYVA)
First Tr Exchange Traded Fd rba indl etf (AIRR)
Amazon (AMZN)
Cme (CME)

View all positions for Cooper Investors Pty

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Alliancebernstein

View all funds holding Halozyme Therapeutics